EndoTheia
Nashville-Davidson, Tennessee, United States · Biotechnology · 9 employees
EndoTheia was founded in 2018 to develop the next generation of flexible endoscopic devices, with the goal of increasing therapeutic yields through added flexibility and dexterity.
Funding history
- Series seed — $500K — Sep 2024
Recent signals
- Nov 19, 2024: Launched EndoTheia, Inc. announces the successful completion of the first-in-human clinical trial for FlexStone, an innovative kidney stone basket.
- Sep 18, 2024: Raised $500K in Series seed
See plans & pricing → Track EndoTheia’s funding, hiring, and signals — with verified contacts — on Fundz.